Login
Toggle navigation
Videos
Categories
Trending
Fullsix Unveils Diverse Pepper Solutions Across Retail, Banking, Hospitality, and Healthcare | Francesco Meani , CEO at Fullsix Spa
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Francesco Meani is the CEO at Fullsix Spa
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Essential End-of-Life Planning You CAN'T Ignore: Secure Your Legacy with RBF Retirement Solutions
00:10:00
Carmen Pérez Baguena on Cobas AM's Retail Sector Investment Strategy
00:10:00
Real Estate Entrepreneur Discusses Market Trends and Investment Strategies | Sven-Olof Johansson, CEO, FastPartner AB FPAR.
00:10:00
Energy Fuels CEO Mark Chelmer Discusses Strong Financial Position and Strategic Growth in Uranium Market
00:10:00
Understanding the Economic Landscape: Perspectives on Financial Health and Long-Term Challenges | Thasunda Brown Duckett, CEO , TIAA.
00:10:00
Économie de printemps : Le 8 mars dernier, nous avons eu le plaisir d'accueillir Monsieur Christian Petit, CEO de Romande Energie Holding SA.
00:10:00
Eurizon's Dedication to Sustainable Asset Management | Saverio Perissinotto ,President, Eurizon Capital.
00:10:00
Unveiling the Future of Gaming: An Exclusive Interview with Global Gaming CEO Mark Boswell
00:10:00
Understanding the U.S. Tax System and Capital Gains
00:10:00
Navigating Direct Indexing: Key Considerations | Mike, a knowledgeable expert from Russell Investments
00:10:00
Rich Friedman on Deflation, Digital Transformation, and Investing with Conviction
00:10:00
Valérie Baudson's Strategic Outlook for Amundi | Valérie Baudson, CEO, Amundi .